Q BioMed Inc
Change company Symbol lookup
Select an option...
QBIO Q BioMed Inc
SNUYF Serinus Energy PLC
ALL Allstate Corp
AMWIX ALPS
CWEN Clearway Energy Inc
ELLI Ellie Mae Inc
TDLIX AB Multi-Manager Select 2050 Fund Class I
MA MasterCard Inc
DNB Dun & Bradstreet Corp
ONCE Spark Therapeutics Inc
Go

Company profile

Q BioMed, Inc., formerly ISMO Tech Solutions, Inc., is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors. The Company intends to develop these assets to provide returns through organic growth, out-licensing, sale or spin-off into new public companies. The Company holds license for a generic drug, Strontium Chloride (SR89). SR89 is a radiopharmaceutical agent and indicated for the treatment of pain associated with metastatic bone cancer. Its asset, MAN-01, is indicated for the treatment of glaucoma. MAN-01 is in pre-clinical stage. The Company is assessing multiple biomedical assets in various areas of healthcare and drug development. It is pursuing a pipeline of therapeutics, diagnostics and orphan drug candidates.

Closing Price
$2.84
Day's Change
0.1425 (5.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.90
Day's Low
2.72
Volume
(Below Average)
Volume:
63,736

10-day average volume:
78,556
63,736
  • Prev Close
    2.69
  • Today's Open
    2.75
  • Day's Range
    2.72-2.90
  • Avg Vol (10-day)
    78.6K
  • Last (time)
    3:58p ET 09/19/18
  • Last (size)
    600
  • 52-Wk Range
    1.67 - 5.90
    LowHigh
  • (11/30/17 - 08/24/18)
    69.76%
  • 74.8%
  • Market Cap
    39.9M
  • Shares Outstanding
    14.1M
  • -1.04
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 0.01
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.